Endocrine

, Volume 32, Issue 1, pp 20–29 | Cite as

Streptozotocin-resistant BRIN-BD11 cells possess wide spectrum of toxin tolerance and enhanced insulin-secretory capacity

  • Hui-Kang Liu
  • Jane T. McCluskey
  • Neville H. McClenghan
  • Peter R. Flatt
Original Paper

Abstract

Since streptozotocin (STZ) exhibits beta-cell toxicity, mediated through diverse mechanisms, multiple toxin resistance can be expected in insulin-secretory cells rendered STZ-resistant. RINm5F, but not all cell lines surviving STZ treatment, possess higher insulin content than native parental cells and additional tolerance against alloxan. To understand the impact of STZ tolerant cell selection on toxin resistance and insulin-secretory function, STZ-resistant BRIN-BD11 cells were generated by iterative acute exposure to 20 mM STZ. These cells, denoted BRINst cells, exhibited resistance to toxic challenges from STZ, H2O2, and ninhydrin. Insulin content and both glucose and arginine-stimulated insulin secretion were significantly enhanced in BRINst cells. The toxin-resistance of BRINst cells was gradually lost during continuous cultivation without STZ challenge. However, enhanced insulin secretory capacity at high passage in BRINst cells persisted. Although total SOD activity was decreased, catalase activity was increased and appeared to be important for the ninhydrin and STZ resistance of BRINst cells. This was associated with reductions of both STZ- and ninhydrin-induced DNA damage, although DNA repair was abolished. Further characterization of cells exhibiting multiple toxin tolerance and an enhanced insulin secretory function could provide useful lessons for understanding of beta-cell survival.

Keywords

Beta-cell destruction DNA damage and repair Insulin secretion Streptozotocin Toxin resistance 

References

  1. 1.
    J.W. Baynes, in: Drugs, Diet, and Disease, ed by P.R. Flatt, C. Ioannides, (Ellis Horwood Limited, 1995)Google Scholar
  2. 2.
    P.R. Flatt, O. Shibier, C. Ioannides, S.K. Swanston Flatt, Exp. Clin. Endocrinol. 93, 193–202 (1989)PubMedCrossRefGoogle Scholar
  3. 3.
    C.C. Rerup, Pharmacol. Rev. 22, 485–518 (1970)PubMedGoogle Scholar
  4. 4.
    P. Bouchard, P. Sai, G. Reach, I. Caubarrere, D. Ganeval, R. Assan, Diabetes 31, 40–45 (1982)PubMedCrossRefGoogle Scholar
  5. 5.
    T. Helgason, M.R. Jonasson, Lancet 2, 716–720 (1981)PubMedCrossRefGoogle Scholar
  6. 6.
    J.H. Karam, P.A. Lewitt, C.W. Young, R.E. Nowlain, B.J. Frankel, H. Fujiya, Z.R. Freedman, G.M. Grodsky, Diabetes 29, 971–978 (1980)PubMedCrossRefGoogle Scholar
  7. 7.
    C.J. Bailey, P.R. Flatt, in: Textbook of Diabetes, ed. by J.C. Pickup, G. Williams (Blackwell Science, Osney Mead, 2003)Google Scholar
  8. 8.
    F. Lally, A.J. Bone, in Textbook of Diabetes, ed. by J.C. Pickup, G. Williams (Blackwell Science, Osney Mead, 2003)Google Scholar
  9. 9.
    M. Elsner, B. Guldbakke, M. Tiedge, R. Munday, S. Lenzen, Diabetologia 43, 1528–1533 (2000)PubMedCrossRefGoogle Scholar
  10. 10.
    W.J. Schnedl, S. Ferber, J.H. Johnson, C.B. Newgard, Diabetes 43, 1326–1333 (1994)PubMedCrossRefGoogle Scholar
  11. 11.
    B.E. Tuch, S. Beynon, M.T. Tabiin, R. Sassoon, R.J. Goodman, A.M. Simpson, J Autoimmun. 10, 239–244 (1997)PubMedCrossRefGoogle Scholar
  12. 12.
    C. Park, J.R. Kim, J.K. Shim, B.S. Kang, Y.G. Park, K.S. Nam, Y.C. Lee, C.H. Kim, Arch. Biochem. Biophys. 362, 217–224 (1999)PubMedCrossRefGoogle Scholar
  13. 13.
    K. Asayama, D. English, A.E. Slonim, I.M. Burr, Diabetes 33, 160–163 (1984)PubMedCrossRefGoogle Scholar
  14. 14.
    K.S. Saini, C. Thompson, C.M. Winterford, N.I. Walker, D.P. Cameron, Biochem. Mol. Biol. Int. 39, 1229–1236 (1996)PubMedGoogle Scholar
  15. 15.
    N. Takasu, I. Komiya, T. Asawa, Y. Nagasawa, T. Yamada, Diabetes 40, 1141–1145 (1991)PubMedCrossRefGoogle Scholar
  16. 16.
    J. Turk, J.A. Corbett, S. Ramanadham, A. Bohrer, M.L. McDaniel, Biochem. Biophys. Res. Commun. 197, 1458–1464 (1993)PubMedCrossRefGoogle Scholar
  17. 17.
    D.M. Kokkinakis, M.A. von Wronski, T.H. Vuong, T.P. Brent, S.C. Schold Jr., Br. J. Cancer 75, 779–788 (1997)PubMedGoogle Scholar
  18. 18.
    M. Murata, A. Takahashi, I. Saito, S. Kawanishi, Biochem. Pharmacol. 57, 881–887 (1999)PubMedCrossRefGoogle Scholar
  19. 19.
    N.A. Berger, Radiat. Res. 101, 4–15 (1985)PubMedCrossRefGoogle Scholar
  20. 20.
    H. Okamoto, Biomed. Biochim. Acta. 44, 15–20 (1985)PubMedGoogle Scholar
  21. 21.
    A. Bast, G. Wolf, R. Oberbaumer, R. Walther, Diabetologia 45, 867–876 (2002)PubMedCrossRefGoogle Scholar
  22. 22.
    H. Chen, E.C. Carlson, L. Pellet, J.T. Moritz, P.N. Epstein, Diabetes 50, 2040–2046 (2001)PubMedCrossRefGoogle Scholar
  23. 23.
    K.D. Kroncke, K. Fehsel, A. Sommer, M.L. Rodriguez, V. Kolb-Bachofen, Biol. Chem. Hoppe. Seyler. 376, 179–185 (1995)PubMedGoogle Scholar
  24. 24.
    K. Bloch, P. Vardi, Int. J. Exp. Diabetes Res. 1, 233–237 (2001)CrossRefGoogle Scholar
  25. 25.
    K.O. Bloch, M. Vorobeychik, K. Yavrians, P. Vardi, Biochem. Pharmacol. 65, 1797–1805 (2003)PubMedGoogle Scholar
  26. 26.
    K.O. Bloch, R. Zemel, O.V. Bloch, H. Grief, P. Vardi, Int. J. Exp. Diabetes Res. 1, 211–219 (2000)PubMedCrossRefGoogle Scholar
  27. 27.
    G. Chen, H.E. Hohmeier, R. Gasa, V.V. Tran, C.B. Newgard, Diabetes 49, 562–570 (2000)PubMedCrossRefGoogle Scholar
  28. 28.
    G. Chen, H.E. Hohmeier, C.B. Newgard, J. Biol. Chem. 276, 766–772 (2001)PubMedCrossRefGoogle Scholar
  29. 29.
    K. Bloch, P. Vardi, Diabetes Metab. Res. Rev. 21, 253–261 (2005)PubMedCrossRefGoogle Scholar
  30. 30.
    Y. Abdel-Wahab, H.-K. Liu, N.H. McClenaghan, P.R. Flatt, Diabetic Med. 23, 33–34 (2006)Google Scholar
  31. 31.
    N.H. McClenaghan, C.R. Barnett, E. Ah-Sing, Y.H. Abdel-Wahab, F.P. O’Harte, T.W. Yoon, S.K. Swanston-Flatt, P.R. Flatt, Diabetes 45, 1132–1140 (1996)PubMedCrossRefGoogle Scholar
  32. 32.
    N.H. McClenaghan, C.R. Barnett, F.P. O’Harte, P.R. Flatt, J Endocrinol. 151, 349–357 (1996)PubMedCrossRefGoogle Scholar
  33. 33.
    V.J. McKelvey-Martin, M.H. Green, P. Schmezer, B.L. Pool-Zobel, M.P. De Meo, A. Collins, Mutat. Res. 288, 47–63 (1993)PubMedGoogle Scholar
  34. 34.
    P.R. Flatt, C.J. Bailey, Diabetologia 20, 573–577 (1981)PubMedCrossRefGoogle Scholar
  35. 35.
    K. Grankvist, J. Sehlin, I.B. Taljedal, Acta Pharmacol. Toxicol. (Copenh.) 58, 175–181 (1986)Google Scholar
  36. 36.
    H. Kaneto, J. Fujii, H.G. Seo, K. Suzuki, T. Matsuoka, M. Nakamura, H. Tatsumi, Y. Yamasaki, T. Kamada, N. Taniguchi, Diabetes 44, 733–738 (1995)PubMedCrossRefGoogle Scholar
  37. 37.
    E. Strandell, S. Sandler, J. Endocrinol. 153, 81–86 (1997)PubMedCrossRefGoogle Scholar
  38. 38.
    S.P. LeDoux, S.E. Woodley, N.J. Patton, G.L. Wilson, Diabetes 35, 866–872 (1986)PubMedCrossRefGoogle Scholar
  39. 39.
    Z. Ling, M. Van de Casteele, D.L. Eizirik, D.G. Pipeleers, Diabetes 49, 340–345 (2000)PubMedCrossRefGoogle Scholar
  40. 40.
    I. Flechner, K. Maruta, V. Burkart, K. Kawai, H. Kolb, U. Kiesel, Diabetes Res. 13, 67–73 (1990)PubMedGoogle Scholar
  41. 41.
    N.S. Kwon, S.H. Lee, C.S. Choi, T. Kho, H.S. Lee, Faseb J. 8, 529–533 (1994)PubMedGoogle Scholar
  42. 42.
    P.R. Flatt, S.K. Swanston Flatt, K.S. Tan, V. Marks, Gen. Pharmacol. 18, 293–297 (1987)PubMedGoogle Scholar
  43. 43.
    S. Lortz, M. Tiedge, T. Nachtwey, A.E. Karlsen, J. Nerup, S. Lenzen, Diabetes 49, 1123–1130 (2000)PubMedCrossRefGoogle Scholar
  44. 44.
    M. Tiedge, H. Steffeck, M. Elsner, S. Lenzen, Diabetes 48, 514–523 (1999)PubMedCrossRefGoogle Scholar
  45. 45.
    N. Takasu, T. Asawa, I. Komiya, Y. Nagasawa, T. Yamada, J. Biol. Chem. 266, 2112–2114 (1991)PubMedGoogle Scholar
  46. 46.
    T. Ishii, H. Iwahashi, R. Sugata, R. Kido, J. Biochem. (Tokyo) 104, 610–615 (1988)Google Scholar
  47. 47.
    M. Poje, B. Rocic, M. Sikirica, I. Vickovic, M. Bruvo, J. Med. Chem. 26, 861–864 (1983)PubMedCrossRefGoogle Scholar
  48. 48.
    C.A. Delaney, D.L. Eizirik, Braz. J. Med. Biol. Res. 29, 569–579 (1996)PubMedGoogle Scholar
  49. 49.
    Y. Uchigata, H. Yamamoto, A. Kawamura, H. Okamoto, J. Biol. Chem. 257, 6084–6088 (1982)PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2007

Authors and Affiliations

  • Hui-Kang Liu
    • 1
    • 2
  • Jane T. McCluskey
    • 1
  • Neville H. McClenghan
    • 1
  • Peter R. Flatt
    • 1
  1. 1.School of Biomedical SciencesUniversity of UlsterColeraineNorthern Ireland, UK
  2. 2.Division of Herbal Drugs and Natural ProductsNational Research Institute of Chinese MedicineTaipeiTaiwan

Personalised recommendations